| Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders DB Johnson, RJ Sullivan, PA Ott, MS Carlino, NI Khushalani, F Ye, ... JAMA oncology 2 (2), 234-240, 2016 | 589 | 2016 |
| Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma ES Gray, H Rizos, AL Reid, SC Boyd, MR Pereira, J Lo, V Tembe, ... Oncotarget 6 (39), 42008, 2015 | 330 | 2015 |
| Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma JH Lee, GV Long, S Boyd, S Lo, AM Menzies, V Tembe, A Guminski, ... Annals of Oncology 28 (5), 1130-1136, 2017 | 287 | 2017 |
| Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1–based immunotherapy SY Lim, JH Lee, TN Gide, AM Menzies, A Guminski, MS Carlino, EJ Breen, ... Clinical Cancer Research 25 (5), 1557-1563, 2019 | 264 | 2019 |
| Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti–programmed cell death 1 antibodies JH Lee, GV Long, AM Menzies, S Lo, A Guminski, K Whitbourne, ... JAMA oncology 4 (5), 717-721, 2018 | 248 | 2018 |
| Transcriptional downregulation of MHC class I and melanoma de-differentiation in resistance to PD-1 inhibition JH Lee, E Shklovskaya, SY Lim, MS Carlino, AM Menzies, A Stewart, ... Nature communications 11 (1), 1897, 2020 | 169 | 2020 |
| Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial GV Long, RPM Saw, S Lo, OE Nieweg, KF Shannon, M Gonzalez, ... The Lancet Oncology 20 (7), 961-971, 2019 | 138 | 2019 |
| Evaluation of commercial kits for purification of circulating free DNA RJ Diefenbach, JH Lee, RF Kefford, H Rizos Cancer genetics 228, 21-27, 2018 | 109 | 2018 |
| Liquid biomarkers in melanoma: detection and discovery SY Lim, JH Lee, RJ Diefenbach, RF Kefford, H Rizos Molecular cancer 17, 1-14, 2018 | 88 | 2018 |
| Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients JH Lee, RP Saw, JF Thompson, S Lo, AJ Spillane, KF Shannon, ... Annals of Oncology 30 (5), 815-822, 2019 | 79 | 2019 |
| Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors JH Lee, AM Menzies, MS Carlino, AC McEvoy, S Sandhu, AM Weppler, ... Clinical Cancer Research 26 (15), 4064-4071, 2020 | 52 | 2020 |
| Metastasis‐specific patterns of response and progression with anti‐PD‐1 treatment in metastatic melanoma JHJ Lee, M Lyle, AM Menzies, MMK Chan, S Lo, A Clements, MS Carlino, ... Pigment Cell & Melanoma Research 31 (3), 404-410, 2018 | 51* | 2018 |
| Circulating tumor DNA predicts outcome from first-, but not second-line treatment and identifies melanoma patients who may benefit from combination immunotherapy G Marsavela, J Lee, L Calapre, SQ Wong, MR Pereira, AC McEvoy, ... Clinical Cancer Research 26 (22), 5926-5933, 2020 | 43 | 2020 |
| PD-1 and PD-L1 inhibitors in melanoma treatment: past success, present application and future challenges J Lee, R Kefford, M Carlino Immunotherapy 8 (6), 733-746, 2016 | 34 | 2016 |
| Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients SY Lim, JH Lee, SJ Welsh, SB Ahn, E Breen, A Khan, MS Carlino, ... Biomarker research 5, 1-12, 2017 | 32 | 2017 |
| Tumor MHC expression guides first-line immunotherapy selection in melanoma E Shklovskaya, JH Lee, SY Lim, A Stewart, B Pedersen, P Ferguson, ... Cancers 12 (11), 3374, 2020 | 26 | 2020 |
| Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexia HY Kim, JK Duong, M Gonzalez, GV Long, AM Menzies, H Rizos, SY Lim, ... Cancer Chemotherapy and Pharmacology 83, 693-704, 2019 | 25 | 2019 |
| COVID-19: the use of immunotherapy in metastatic lung cancer AP Davis, M Boyer, JH Lee, SC Kao Immunotherapy 12 (8), 545-548, 2020 | 24 | 2020 |
| Monitoring melanoma using circulating free DNA RJ Diefenbach, JH Lee, H Rizos American Journal of Clinical Dermatology 20 (1), 1-12, 2019 | 24 | 2019 |
| Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis S Gandini, I Zanna, SP De Angelis, E Cocorocchio, P Queirolo, JH Lee, ... Critical Reviews in Oncology/Hematology 157, 103187, 2021 | 21 | 2021 |
